Dr Riyaz Shah· @DrRiyazShah · X·· 4 hours agoScore70
Body
HERON-lung01; Ruzaltatug rezetecan (will we call this Ruiz-Rez is my overriding thought?) in common mEGFR; n498; mPFS HR 0.47 -3m longer ; mDOR 8.5m ; tolerability looks somewhat more palatable than izabren? #ESMO26
19 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
LBA13matched by Proffered paper 1: Breast cancer, early and advanced stage
Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)
https://esmocongress.esmo.orgSource: Dr Riyaz Shah · x.com